Saudi Arabia
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
-285.61 |
Feb. 10, 2025 | USD 8.71 | -0.52% |
|
Saudi Arabia |
The Clinical Trials company in Saudi Arabia with the highest Price to Earnings Ratio (P/E) is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at -285.61.
The Clinical Trials company in Saudi Arabia with the lowest Price to Earnings Ratio (P/E) is Saudi Pharmaceutical Industries and Medical Appliances Corporation (Saudi Stock Exchange: 2070.SR) at -285.61.
The top 10 Clinical Trials companies in Saudi Arabia by Price to Earnings Ratio (P/E) are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.
The bottom 10 Clinical Trials companies in Saudi Arabia by Price to Earnings Ratio (P/E) are and Saudi Pharmaceutical Industries and Medical Appliances Corporation.